Start
November 18, 2026 - 6:00 pm
End
November 18, 2026 - 7:00 pm
IPVS Post-Conference Webinar: Best of IPVS 2026 Abstracts
Wednesday, 18 November 2026
18:00 PM (Geneva) / 12:00 EST (New York)
Join this free webinar to explore nine impactful abstracts from the IPVS 2026 Conference, highlighting new findings, innovative approaches, and emerging research shaping the future of HPV science. Discover key conference insights and hear directly from selected authors as they share their work with the global HPV community.
Moderators: Andreia Albuquerque, MD, PhD and Elisabeth McClymont, PhD
Topics and Faculty:
1.) Quadrivalent HPV vaccination before pregnancy and the risk of adverse pregnancy outcomes – Mr. Zhongsong Zhang
2.) SIRT1 inhibition disrupts replication-checkpoint control and reveals a p53-p21 vulnerability in HPV-driven cancers – Prof. Marisa Gariglio
3.) Hybrid ecDNA rewires HPV oncogene regulation through a novel epigenetic architecture – Dr. Takuya Nakagawa
4.) Early HPV-associated tonsillar lesions and oral HPV mRNA as a biomarker of biologically active oropharyngeal carcinogenesis – Dr. Masashi Mori
5.) Efficacy of one dose of HPV vaccines in women 18 to 30: the PRISMA trial – Mr. Rolando Herrero
6.) Evidence of HPV herd immunity among young women following community HPV vaccination – Mr. Romain Fantin
7.) Changes in HPV vaccination coverage following the single-dose schedule switch: a mixed-methods approach – Dr. Soim Park
8.) Large-scale evaluation of HPV analytical sensitivity thresholds for detection of invasive cervical cancer – Prof. Joakim Dillner
9.) HPV test-and-treat combined with 9-valent HPV vaccination in African women living with HIV: Primary outcomes from the AMC-099/COVENANT trial – Dr. Carla Chibwesha
This webinar will be recorded. If you have missed the previous IPVS webinars, you can watch the videos on demand on the IPVS members’ website. Recording, reproducing, or distributing the webinar content in any form is strictly prohibited.
